- Proven clinical technology (TLC-1000)
- Commercial therapeutic laser business and brand developed over last 17 years
- No debt
- Positive cash flow / double digit growth
- PDC cancer destruction in animals helps pay for human trials
- Competitive technical advantage (Cellular pathways: iNOS, ATP, Na+ / K+)
- Large addressable US market ($ billions)
- Future technology (Patented biofeedback technology and patented PDC cancer destruction)
- Opportunity for growth (revenue, profit)
- IP protection (multiple issued patents)
- Experienced management team (20+ years)
- Clear vision and execution strategy
For more information please contact Greg Bewsh at 1-866-843-5273 or visit www.theralase.com
Thanks for great information you write it very clean. I am very lucky to get this tips from you.
ReplyDeleteClinical Technology